Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Stomach Neoplasms 2Multiple Myeloma 2Colorectal Neoplasms 2Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Hematologic Neoplasms 1Esophageal Neoplasms 1Desmoid Tumors 1Anemia 1

Interventions

Imatinib Mesylate 3Cryosurgery 3nirogacestat 2Blood Specimen Collection 2vactosertib 1strattice 1liposomal doxorubicin 1Toremifene 1Taxes 1Surveys and Questionnaires 1Sunitinib 1Sirolimus 1Saline Solution 1Radiofrequency Ablation 1Pregnancy 1Nivolumab 1Magnetic Resonance Spectroscopy 1Hydroxyurea 1High-Intensity Focused Ultrasound Ablation 1Embolization, Therapeutic 1Electrochemotherapy 1Doxorubicin 1Data Collection 1Cyclophosphamide 1Cryotherapy 1Bleomycin 1Biopsy 1Albumin-Bound Paclitaxel 1Abdominoplasty 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Desmoid Tumors × vactosertib × Clear all
NCT03802084 2024-05-13

A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor

Yonsei University

Phase 1/2 Completed
24 enrolled
Sarcoma

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡